Coronavirus: take a stock on vaccines and therapies developed in the world

Published by Laurent P., Caroline J., Manon C. · Published on 30 July 2021 at 11h53 · Updated on 30 July 2021 at 14h14
Take a stock on Covid-19 vaccines and treatments across the world. Where are the first vaccines at? Are there effective Covid-19 treatments? What are the latest discoveries and breakthroughs performed by scientists?

Even though lockdown and curfew measures implemented everywhere in the world seem to have been more or less effective in the fight against the spread of the coronavirus, the number of people infected by COVID-19 in the rest of the world keeps on rising. So, to face this world’s health crisis, searchers and health professionals have been working hard to try and find an effective medication to erase COVID-19. If the vaccine may not be used for several months, clinical trials are currently carried out in some places of the globe to complete the anti-Covid arsenal.

Dexamethasone, Interferon alpha-2b, Molnupiravirmonoclonal antibodiesCalquence... As many treatments doctors from all around the world test on patients at different stage of the disease within clinical trials. And if you do not know where to start with all these tests and vaccine prototypes, we give you a list of treatments and vaccines currently studied to have a big picture of the current research works.

Vaccines studied in the world:

Vaccination en France : un bilan quotidien dès le mardi 5 janvier 2021Vaccination en France : un bilan quotidien dès le mardi 5 janvier 2021Vaccination en France : un bilan quotidien dès le mardi 5 janvier 2021Vaccination en France : un bilan quotidien dès le mardi 5 janvier 2021 Vaccination in France: How many people are vaccinated as of Wednesday 4 August 2021
How many people have been given the first dose of Covid-19 vaccine in France? What are the regions vaccinating the most? This Wednesday 4 August 2021, here are how many people have been given the first dose, and been fully vaccinated in France since December 27, 2020. Keep reading to find out more about the number of people vaccinated per region. [Read more]

Vaccination dans le monde : quel est le pourcentage de population vaccinée par pays ?Vaccination dans le monde : quel est le pourcentage de population vaccinée par pays ?Vaccination dans le monde : quel est le pourcentage de population vaccinée par pays ?Vaccination dans le monde : quel est le pourcentage de population vaccinée par pays ? Vaccine in the world as of Wednesday 4 August 2021: the percentage of people vaccinated by country?
As many countries have started to vaccinate people against coronavirus in late 2020, what is the percentage of people vaccinated in comparison with the total number of inhabitants in each country? Sortiraparis delivers a daily report on the vaccine situation in the world. Here are the latest data as of Wednesday 4 August 2021. [Read more]

Coronavirus : le point sur les reconfinements et restrictions en EuropeCoronavirus : le point sur les reconfinements et restrictions en EuropeCoronavirus : le point sur les reconfinements et restrictions en EuropeCoronavirus : le point sur les reconfinements et restrictions en Europe Coronavirus: The European Union ordered a new antibody therapy
This Wednesday July 28, the European Union announced they have secured a deal for a new experimental coronavirus therapy, Sotrovimab, developed by UK laboratory GSK. A promising monoclonal antibody therapy. [Read more]

Covid : Pfizer annonce que son vaccin est efficace contre les variants britanniques et sudafricainsCovid : Pfizer annonce que son vaccin est efficace contre les variants britanniques et sudafricainsCovid : Pfizer annonce que son vaccin est efficace contre les variants britanniques et sudafricainsCovid : Pfizer annonce que son vaccin est efficace contre les variants britanniques et sudafricains Covid: Pfizer vaccine less effective against the South African variant, a study finds
Pfizer covid vaccine is said to be less effective against the South African variant... This is at least what an Israeli study found on the matter, stating this strain is likely to "break through" the vaccine. The study shifts focus of the results from the previous study carried out by the American laboratory, explaining their vaccine was working for at least six months against all variants, and especially the South African strain. [Read more]

Vaccination : "On a eu tort de manquer d'ambition, de folie" en Europe, estime MacronVaccination : "On a eu tort de manquer d'ambition, de folie" en Europe, estime MacronVaccination : "On a eu tort de manquer d'ambition, de folie" en Europe, estime MacronVaccination : "On a eu tort de manquer d'ambition, de folie" en Europe, estime Macron Covid: the time period between Pfizer and Moderna vaccine doses will be extended to 42 days
Olivier Véran announced in an interview with Journal du Dimanche that the time period between the two doses of vaccine will be extended to 42 days for patients given the Pfizer or Moderna vaccine. [Read more]

Le vaccin contre la Covid d'AstraZeneca "sûr et efficace" selon The LancetLe vaccin contre la Covid d'AstraZeneca "sûr et efficace" selon The LancetLe vaccin contre la Covid d'AstraZeneca "sûr et efficace" selon The LancetLe vaccin contre la Covid d'AstraZeneca "sûr et efficace" selon The Lancet Covid: Valneva vaccine soon to initiate phase 3 of clinical trials
This Wednesday April 21, French-Austrian laboratory Valneva announced they are initiating phase 3 of their clinical trial of their candidate vaccine. They also announced they will initiate talks country by country as to deliver their Covid candidate vaccine, for lack of deal with the European Union. [Read more]

Covid : le second vaccin de Sanofi ne sera pas prêt en 2021Covid : le second vaccin de Sanofi ne sera pas prêt en 2021Covid : le second vaccin de Sanofi ne sera pas prêt en 2021Covid : le second vaccin de Sanofi ne sera pas prêt en 2021 Pfizer: France has launched the vaccine production in the country
According to news from our peers from Journal du Dimanche, the manufacturing of the Pfizer/BioNTech vaccine is to begin in France, at Delpharm, an expert in packing pharmaceutical product, starting Wednesday April 7. This is the very first Covid vaccine produced in France. In all 250 million doses are to be issued by the end of the year, according to Industry Minister Agnès Pannier-Runacher. [Read more]

Vaccin contre la Covid : c'est quoi, l'ARN messager ?Vaccin contre la Covid : c'est quoi, l'ARN messager ?Vaccin contre la Covid : c'est quoi, l'ARN messager ?Vaccin contre la Covid : c'est quoi, l'ARN messager ? AstraZeneca vaccine particularly effective in people aged 65+, a Scottish study finds
Is AstraZeneca vaccine effective against severe Covid in elderly people? This is what a study carried out by the Edinburgh and Glasgow universities found, only available in preprint and currently studied to be published. If approved by a scientific committee, this observation could be a game changer for the French vaccination strategy. [Read more]

Covid : Johnson & Johnson demande une autorisation pour son vaccin en urgence aux Etats-UnisCovid : Johnson & Johnson demande une autorisation pour son vaccin en urgence aux Etats-UnisCovid : Johnson & Johnson demande une autorisation pour son vaccin en urgence aux Etats-UnisCovid : Johnson & Johnson demande une autorisation pour son vaccin en urgence aux Etats-Unis Johnson & Johnson vaccine to be delivered to France sooner than expected
During the press brief held this Thursday April 22, Health Minister Olivier Véran announced the Johnson & Johnson vaccine will start to be given starting this Saturday April 24 in pharmacies. The vaccine arrives after being assessed safe on Tuesday April 20 by the European Medicines Agency. [Read more]

Covid : le second vaccin de Sanofi ne sera pas prêt en 2021Covid : le second vaccin de Sanofi ne sera pas prêt en 2021Covid : le second vaccin de Sanofi ne sera pas prêt en 2021Covid : le second vaccin de Sanofi ne sera pas prêt en 2021 Covid: Sanofi’s second vaccine initiate human clinical trial
Is Sanofi catching up the race for vaccine? Even though they are still far behind, the French laboratory announced this Friday March 12 they are launching the first human clinical trials of their vaccine developed in partnership with American biotech Translate Bio. [Read more]

Coronavirus : premier test de vaccin sur l'homme cet été par l'Institut PasteurCoronavirus : premier test de vaccin sur l'homme cet été par l'Institut PasteurCoronavirus : premier test de vaccin sur l'homme cet été par l'Institut PasteurCoronavirus : premier test de vaccin sur l'homme cet été par l'Institut Pasteur Covid: Institut Pasteur to stop developing their main vaccine, as results are not forthcoming
Bad news in the fight against Covid! Institut Pasteur has announced they are stopping the development of their main vaccine project - currently completing clinical trial - as results are not forthcoming. A vaccine that was yet tested in humans this summer and that yet had encouraging results. [Read more]

Vaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur CaumesVaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur CaumesVaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur CaumesVaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur Caumes Covid: the second dose of the vaccine to be given in France 3 to 4 weeks later, as planned
This Saturday January 23, to face tensions rising from the Covid vaccine distribution around the world, the Haute Autorité de Santé has announced in a release they are recommending to defer the second dose of vaccine for 42 days, namely six weeks instead of four. A recommendation Health Minister Olivier Véran has decided not to comply with, as he would rather bet on safety. The second dose will be inoculated 28 days after the first injection, as initially decided. [Read more]

Coronavirus : le vaccin russe "opérationnel à 100%" et en circulation dès janvier 2021Coronavirus : le vaccin russe "opérationnel à 100%" et en circulation dès janvier 2021Coronavirus : le vaccin russe "opérationnel à 100%" et en circulation dès janvier 2021Coronavirus : le vaccin russe "opérationnel à 100%" et en circulation dès janvier 2021 Covid: Sputnik V vaccine “light” version approved in Russia
Russian coronavirus Sputnik V vaccine "light" version has been approved. This is what the Russian Direct Investment Fund announced this early May, 2021 saying that only one dose of Sputnik V could be enough to protect people vaccinated. The goal? Bringing a “temporary” solution to countries the most hit by the pandemic and enable to eradicate the spread of the virus quicker. [Read more]

Coronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai cliniqueCoronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai cliniqueCoronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai cliniqueCoronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai clinique Covid: German vaccine CureVac in turmoil?
Bad news for CureVac vaccine... This Wednesday June 16, the German laboratory announced their vaccine - developed with pharmaceutical and agrochemical group Bayer - did not deliver the expected results during the latest clinical trial phase, with 47% effectiveness. Disappointing results likely to slow down vaccine marketing. [Read more]

Vaccin contre la Covid : le produit de Moderna protégerait pendant trois moisVaccin contre la Covid : le produit de Moderna protégerait pendant trois moisVaccin contre la Covid : le produit de Moderna protégerait pendant trois moisVaccin contre la Covid : le produit de Moderna protégerait pendant trois mois Covid: Sanofi vaccine to be marketed by December 2021
Sanofi France CEO Olivier Bogillot announced this July 5th on France Inter the vaccine developed by the laboratories will be available by December 2021. The vaccine is currently completing phase 3 of their trial. [Read more]

Coronavirus : Johnson & Johnson suspend les essais de son vaccin en raison d'un patient maladeCoronavirus : Johnson & Johnson suspend les essais de son vaccin en raison d'un patient maladeCoronavirus : Johnson & Johnson suspend les essais de son vaccin en raison d'un patient maladeCoronavirus : Johnson & Johnson suspend les essais de son vaccin en raison d'un patient malade Covid: Nanocovax, the Vietnamese vaccine to start human testing
As many Covid vaccines are already being issued, Vietnam is just starting human testing his product developed by laboratory Nanogen, Nanocovax. [Read more]

Pfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froidPfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froidPfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froidPfizer et BioNtech préparent des vaccins en poudre pour palier la contrainte du froid Pfizer and BioNTech are making powdered vaccines to get round the refrigeration constraint
A few days ago already Pfizer and BioNTech announced their vaccines against coronavirus were over 95% effective! The only flaw is that these two products are to be stored at minus 80 degrees Celsius (-112°F), leading to logistical issues. Both laboratories are working on a powdered version to get round the problem. [Read more]

Coronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageantsCoronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageantsCoronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageantsCoronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageants Coronavirus: Ose Immunotherapeutics vaccine delivers encouraging results
French laboratory Ose Immunotherapeutics has released encouraging results as for candidate vaccine against coronavirus, adding they will initiate the clinical phase in the first quarter of the year 2021. [Read more]

Treatments under clinical trial:

Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés"Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés"Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés"Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés" Covid: Pfizer to develop two treatments against the virus
Two treatments against Covid are being studied, but have delivered encouraging primary results… This is what Pfizer France director David Lepoittevin announced this Friday April 9, stating that one of them was to be given orally, the other one intravenously. Two medicines that – if trials show effectiveness – could complete the existing arsenal amid the fight against coronavirus. [Read more]

Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés"Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés"Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés"Coronavirus et Chloroquine : l'IHU du professeur Raoult "continuera les traitements les plus adaptés" Covid: take a stock on Molnupiravir, drugmaker Merck’s promising therapy against the virus
Good news amid the fight against Covid! Drugmakers Merck and Ridgeback Bio have announced their molnupiravir therapy against the virus led to promising results. The therapy is said to significatively reduced patients’ viral load. A medication given orally and currently completing clinical trials. [Read more]

Covid : deux traitements par anticorps monoclonaux désormais autorisés en FranceCovid : deux traitements par anticorps monoclonaux désormais autorisés en FranceCovid : deux traitements par anticorps monoclonaux désormais autorisés en FranceCovid : deux traitements par anticorps monoclonaux désormais autorisés en France Covid: France has approved two monoclonal antibody therapies
This Monday March 15, the Agence du Médicament (French Medicines Agency) announced that two monoclonal antibody therapies, namely REGN-COV2 and Eli Lilly laboratory's therapy based on bamlanivimab and etesevimab were now approved in France. [Read more]

Coronavirus : un traitement prometteur découvert par l'Institut Pasteur de LilleCoronavirus : un traitement prometteur découvert par l'Institut Pasteur de LilleCoronavirus : un traitement prometteur découvert par l'Institut Pasteur de LilleCoronavirus : un traitement prometteur découvert par l'Institut Pasteur de Lille Institut Pasteur Lille's promising treatment clinical trials delyed by the Minister
And what if the cure against coronavirus already exists? In September 2020, searchers from Lille Institut Pasteur discovered the existence of a molecule potentially active against the virus and, in all likelihood, not leading to side effects. The therapy has been allowed by the ANSM to launch in-human clinical trial. [Read more]

Covid-19 : le traitement aux anticorps d'Eli Lilly autorisé aux Etats-Unis par la FDACovid-19 : le traitement aux anticorps d'Eli Lilly autorisé aux Etats-Unis par la FDACovid-19 : le traitement aux anticorps d'Eli Lilly autorisé aux Etats-Unis par la FDACovid-19 : le traitement aux anticorps d'Eli Lilly autorisé aux Etats-Unis par la FDA Covid: Eli Lilly antibody therapy said to reduce hospitalization risks, a study finds
As the race for Covid vaccines and therapies is speeding up all over the world, drugmaker Eli Lilly announced this Wednesday March 10 their antibody therapy mixing Bamlanivimab and Etsesevimab is said to reduced by 87% hospitalization and death risk in the event of severe infection. A combined therapy that received emergency use authorization back to late February from the Food & Drug Administration. [Read more]

Covid : la Colchicine, un traitement prometteur contre le virus ?Covid : la Colchicine, un traitement prometteur contre le virus ?Covid : la Colchicine, un traitement prometteur contre le virus ?Covid : la Colchicine, un traitement prometteur contre le virus ? Covid: Colchicine not working in hospitalized sick, Recovery trial found
Is Colchicine not working in Covid sick already at the hospital? This is the conclusion found by the Recovery trial in a study released this Tuesday May 18, explaining the use of this therapy "was not associated with reductions in mortality, duration of hospital stay, or risk of progressing to invasive mechanical ventilation or death". Yet, this was a promising molecule, according to Montreal Heart Institute in a study released in March 2020 explaining Colchicine was said to be effective against Coronavirus, according to primary results from a clinical trial. [Read more]

Covid : Xav-19, le traitement aux anticorps made in France en cours d'essai cliniqueCovid : Xav-19, le traitement aux anticorps made in France en cours d'essai cliniqueCovid : Xav-19, le traitement aux anticorps made in France en cours d'essai cliniqueCovid : Xav-19, le traitement aux anticorps made in France en cours d'essai clinique Covid: Xav-19, the French antibody-based treatment undergoing clinical trials
And what if, amid the fight against Covid, one could rely – in addition to the upcoming vaccine – on antibody-based treatments? After Bamlanivimab – the treatment developed by the Eli Lilly laboratory – or even Regeneron, this is now French Nantes-based laboratory Xenothera’s turn to present a treatment undergoing clinical trials, Xav-19. A treatment that could be issued from Spring 2021. [Read more]

Coronavirus : le Calquence, un traitement efficace contre les chocs cytokiniques ?Coronavirus : le Calquence, un traitement efficace contre les chocs cytokiniques ?Coronavirus : le Calquence, un traitement efficace contre les chocs cytokiniques ?Coronavirus : le Calquence, un traitement efficace contre les chocs cytokiniques ? Covid-19: Calquence, an effective treatment against cytokine shocks?
Is Claquence an effective treatment to fight against Covid-19? Pharmaceutical group AstraZeneca has announced phase 2 of their clinical trials with this potential treatment to coronavirus “did not meet the primary endpoint”. A clinical trial which point was to try and assess its effect against cytokine shocks, this violent inflammatory response from the immune system, combined with Covid-19 infection. [Read more]

Coronavirus : certains stéroïdes efficaces contre les cas graves selon trois nouvelles étudesCoronavirus : certains stéroïdes efficaces contre les cas graves selon trois nouvelles étudesCoronavirus : certains stéroïdes efficaces contre les cas graves selon trois nouvelles étudesCoronavirus : certains stéroïdes efficaces contre les cas graves selon trois nouvelles études Coronavirus: some steroids effective against severe Covid-19, three new studies say
Are some steroids effective against severe Covid-19? This is the conclusion three studies found published in the Journal of the American Medical Association. Their effectiveness led the WHO to authorize their use for cases concerned. [Read more]

Coronavirus : le Kevzara peu efficace comme traitement au virus selon SanofiCoronavirus : le Kevzara peu efficace comme traitement au virus selon SanofiCoronavirus : le Kevzara peu efficace comme traitement au virus selon SanofiCoronavirus : le Kevzara peu efficace comme traitement au virus selon Sanofi Coronavirus: Kevzara underperforming as a cure to the virus, Sanofi says
This Tuesday September 1, Sanofi said they were ending their clinical trial on Kevzara as a cure against coronavirus, after noting results of this study were inconclusive. [Read more]

Coronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'InsermCoronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'InsermCoronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'InsermCoronavirus : des "résultats positifs" pour le traitement remdesivir/diltiazem selon l'Inserm Coronavirus: “Positive results” for the remdesivir/diltiazem treatment the Inserm says
Searchers from the French National Institute for Health and Medical Research (Inserm) in Lyon showed that mixing two medicines, remdesivir and diltiazem, gave “positive results” for a pre-clinical phase. A new step for the discovery of an effective treatment against coronavirus. [Read more]

Coronavirus : la chloroquine, un traitement prometteur ? Coronavirus : la chloroquine, un traitement prometteur ? Coronavirus : la chloroquine, un traitement prometteur ? Coronavirus : la chloroquine, un traitement prometteur ? Coronavirus: chloroquine use subject to a control
Currently into lockdown in France, the medical staff keeps fighting against coronavirus, and a cure based on chloroquine is at the heart of the debate. This Monday March 23rd, 2020, Olivier Véran announces to supervise the medication as a cure to Covid-19. [Read more]

Coronavirus : le remdesivir, traitement efficace contre les orages de cytokine ?Coronavirus : le remdesivir, traitement efficace contre les orages de cytokine ?Coronavirus : le remdesivir, traitement efficace contre les orages de cytokine ?Coronavirus : le remdesivir, traitement efficace contre les orages de cytokine ? Coronavirus: the European Union allows putting Remdesivir on the market
Remdesivir is at the heart of research against coronavirus and has been adopted in the United-States in early May. The European Union is now validating the authorization to put the treatment on the market. [Read more]

Coronavirus : le cocktail lopinavir/ritonavir inefficace selon l'essai RecoveryCoronavirus : le cocktail lopinavir/ritonavir inefficace selon l'essai RecoveryCoronavirus : le cocktail lopinavir/ritonavir inefficace selon l'essai RecoveryCoronavirus : le cocktail lopinavir/ritonavir inefficace selon l'essai Recovery Coronavirus: the lopinavir/ritonavir cocktail ineffective, the Recovery trail says
Is the lopinavir/ritonavir blend to fight against coronavirus ineffective? This is what several leaders of the Recovery trial say. [Read more]

Coronavirus : l'interféron alpha-2b, un traitement prometteur ?Coronavirus : l'interféron alpha-2b, un traitement prometteur ?Coronavirus : l'interféron alpha-2b, un traitement prometteur ?Coronavirus : l'interféron alpha-2b, un traitement prometteur ? Covid: Interferon Alpha-2b, a promising therapy soon to be used in France?
Is interferon alpha-2b effective to fight against Covid? This is what a study found as it focused on the antiviral and has been released this May 15, 2020 in Frontiers in Immunology. A therapy first used against Hepatitis C, dengue, and even some cancers, specifically in South America, and enabling to dramatically improve coronavirus patient’s states of health. [Read more]

Coronavirus : la chlorpromazine, médicament contre la bipolarité, protègerait du COVID-19 ?Coronavirus : la chlorpromazine, médicament contre la bipolarité, protègerait du COVID-19 ?Coronavirus : la chlorpromazine, médicament contre la bipolarité, protègerait du COVID-19 ?Coronavirus : la chlorpromazine, médicament contre la bipolarité, protègerait du COVID-19 ? Coronavirus: does chlorpromazine, medication against bipolarity, protect against COVID-19?
Medication against bipolarity, chlorpromazine could protect yourself against coronavirus. According to the Sainte-Anne University Hospital, patients treated with chlorpromazine are less hit by COVID-19 and symptomatic cases are rare. The Institut Pasteur has just launched a study. [Read more]

Coronavirus : l'Anakinra, un traitement prometteur ?Coronavirus : l'Anakinra, un traitement prometteur ?Coronavirus : l'Anakinra, un traitement prometteur ?Coronavirus : l'Anakinra, un traitement prometteur ? Coronavirus: Anakinra, a promising treatment?
Is Anakinra an effective treatment against coronavirus? According to a French study released in The Lancet, the medicine usually prescribed for rheumatic diseases released encouraging results on severe Covid-19 forms. First results that will have to be confirmed on a greater number of patients. [Read more]

Coronavirus : Le tocilizumab, le nouveau médicament prometteurCoronavirus : Le tocilizumab, le nouveau médicament prometteurCoronavirus : Le tocilizumab, le nouveau médicament prometteurCoronavirus : Le tocilizumab, le nouveau médicament prometteur Tocilizumab, the covid treatment to dramatically reduce deaths, Recovery says
This Thursday February 11, the Oxford University released the results of Recovery clinical trial on Tocilizumab, a medication generally used in rheumatology, but here, it is used to lower the number of Covid patients in ICU. And results are particularly encouraging, echoing the study led in April 2020 by AP-HP. Here is more on the matter. [Read more]

Coronavirus : l'interféron bêta, un traitement efficace selon une étudeCoronavirus : l'interféron bêta, un traitement efficace selon une étudeCoronavirus : l'interféron bêta, un traitement efficace selon une étudeCoronavirus : l'interféron bêta, un traitement efficace selon une étude Coronavirus: interferon beta, an effective treatment soon to be used in France?
According to the pharmaceutical company Synairgen, clinical trials about a treatment based on interferon beta – usually used against sclerosis – gave “very significative” outcomes against coronavirus. A treatment that could relieve severe cases with respiratory distress. [Read more]

Coronavirus : les transfusions de plasma efficace contre la maladieCoronavirus : les transfusions de plasma efficace contre la maladieCoronavirus : les transfusions de plasma efficace contre la maladieCoronavirus : les transfusions de plasma efficace contre la maladie Coronavirus: are plasma transfusions effective against the disease?
Is plasma transfusion an effective solution against Covid? This is one of the ongoing study topic as to cure coronavirus and it seems to deliver rather mixed results, despite an encouraging Chinese study released in April 2020. Here is more on the matter. [Read more]

Practical information

Comments
Refine your search
Refine your search
Refine your search
Refine your search